===D-Wave Quantum (QBTS) reported earnings on Thur 8 May 25 (b/o)

 

D-Wave Quantum (QBTS) on Thursday reported a smaller-than-expected first quarter loss while revenue topped views as investors focus on the near-term growth outlook for quantum computing stocks.

For the March quarter, D-Wave reported a 2-cent loss on an adjusted basis versus an 11-cent loss a year earlier. Revenue rose 509% to $15 million.

Wall Street analysts had forecast a 4-cent loss on revenue of $10.5 million.

Q1 bookings fell 64% to $1.6 million, the company said.

Further, D-Wave in February won a big deal in Germany. The Jülich Supercomputing Centre bought one of D-Wave's quantum systems.

==IonQ (IONQ) reported earnings on Wed 7 May 25 (a/h)

 

IonQ (IONQ) reported a smaller first quarter loss from a year earlier, in line with estimates, while revenue also met expectations. Further, IonQ announced two new acquisitions.

IonQ said it will acquire Lightsynq Technologies, a Boston-based startup founded by former Harvard University quantum memory experts. Also, IonQ said it has agreed to buy Capella Space. It called Capella a "a signals platform leader for top-secret government and commercial applications."

Meanwhile, IonQ this week completed the acquisition of a controlling stake in ID Quantique. Also, IonQ last year acquired a quantum networking company called Qubitekk.

Quantum Computing Stocks: IonQ Targets Networking

The company is expanding from quantum compute into building quantum key distribution (QKD) networks, eyeing U.S. government business. The quantum communications networks would include satellite to satellite links in space and satellite to ground station links.

"China has announced progress on QKD in space and is imperative for economic and national security that we lead in all dimensions, theaters and segments of quantum networking," said IonQ Chief Executive Niccolo de Masi on its earnings call with Wall Street analysts.

Cybersecurity is a growing concern. Quantum computers are expected to eventually overpower current data encryption technologies. And, hackers could make use of that capability. So quantum communications networks will be needed to support quantum computers located in data centers, analysts say.

===Amentum Holdings (AMTM) reported earnings on Tue 6 May 25 (a/h)

 

Amentum Holdings beats by $0.06, beats on revs; reaffirms FY25 EPS guidance, narrows FY25 revenue guidance

• Reports Q1 (Mar) earnings of $0.53 per share, excluding non-recurring items, $0.06 better than the FactSet Consensus of $0.47; revenues rose 70.2% year/year to $3.49 bln vs the $3.43 bln FactSet Consensus.
• Co issues guidance for FY25, sees EPS of $2.00-2.20, excluding non-recurring items, vs. $2.11 FactSet Consensus; sees FY25 revs of $13.85-14.15 bln from $13.8-14.2 bln vs. $14.06 bln FactSet Consensus.

==Sequans Communications SA (SQNS) reported earnings on Tue 6 May 25 (b/o)

 

COLOMBES, France (AP) — COLOMBES, France (AP) — Sequans Communications SA (SQNS) on Tuesday reported a loss of $7.3 million in its first quarter.

On a per-share basis, the Colombes, France-based company said it had a loss of 29 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 24 cents per share.

The chip company posted revenue of $8.1 million in the period.

Black Rifle Coffee Co. (BRCC) reported earnings on Mon 5 May 25 (a/h)

BRC Inc. operates as a veteran-controlled, non-alcoholic beverage company that uniquely blends high-quality coffee production with military and firearms-themed merchandise.

• Sector: Consumer Defensive
• Industry: Packaged Foods
• Full Time Employees: 551
• Founded in 2014 
• HQ in Salt Lake City, Utah
• https://www.blackriflecoffee.com

IPO: February 10, 2022 via a merger with a special purpose acquisition company, or SPAC, affiliate of SilverBox Capital

 ** charts after earnings **

SALT LAKE CITY--(BUSINESS WIRE)--BRC Inc. (NYSE: BRCC), a Veteran-founded, mission-driven premium beverage company, today announced financial results for the first quarter of fiscal year 2025.

• In Q1 2025, packaged coffee distribution increased by 12.2 percentage points to 50.2% ACV and Ready-to-Drink ("RTD") coffee distribution grew by 5.1 percentage points to 47.9% ACV compared to Q1 2024.
• Wholesale revenue declined 6.0% compared to Q1 2024, primarily due to the net reduction of $8.5 million in prior-year barter transaction revenue.
• Net loss was $7.8 million in Q1 2025, a decrease of $9.7 million compared to net income of $1.9 million in Q1 2024. Adjusted EBITDA was $0.9 million, down $11.6 million from $12.5 million in Q1 2024.

AirSculpt Technologies (AIRS) reported earnings on Fri 2 May 25 (b/o)

 ** charts after earnings **

 

 

First Quarter 2025 Results

• Case volume was 3,076 for the first quarter of 2025, representing a 17.9% decline from the fiscal year 2024 first quarter case volume of 3,746;
• Revenue declined 17.3% to $39.4 million from $47.6 million in the fiscal year 2024 first quarter;
• Net loss for the quarter was $2.8 million compared to net income of $6.0 million in the fiscal year 2024 first quarter; and Adjusted EBITDA was $3.8 million compared to $7.3 million for the fiscal year 2024 first quarter.

2025 Outlook

The Company projects full year 2025 revenue and adjusted EBITDA guidance as follows:

• Revenues of approximately $160 to $170 million
• Adjusted EBITDA of approximately $16 to $18 million

-=CVS Health (CVS) reported earnings on Thur 1 May 25 (b/o)

 

Novo Nordisk A/S announces that CVS Caremark, the country's largest Pharmacy Benefit Manager has decided that Wegovy injection 2.4 mg, the most widely prescribed and studied GLP-1 for weight loss, will soon be the preferred GLP-1 medicine on its largest commercial template formularies

• Wegovy will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark, the largest Pharmacy Benefit Manager in the US, effective July 1, 2025.
• Novo Nordisk is focused on new ways to drive access and affordability for Wegovy, the most widely prescribed and studied GLP-1 for weight loss that is fully available nationwide.

CVS Health beats by $0.55, reports revs in-line; raises FY25 EPS above consensus

• Reports Q1 (Mar) earnings of $2.25 per share, excluding non-recurring items, $0.55 better than the FactSet Consensus of $1.70; revenues rose 7.0% year/year to $94.59 bln vs the $93.66 bln FactSet Consensus.
• Co issues upside guidance for FY25, sees EPS of $6.00-6.20, excluding non-recurring items, vs. $5.92 FactSet Consensus and prior guidance of $5.75-6.00.
  • Raised cash flow from operations guidance to approximately $7.0 billion from approximately $6.5 billion
• CVS Health to exit the individual exchange business

===ADT (ADT ) reported earnings on Thur 27 Feb 25 (b/o)

 

 ADT reports EPS in-line, beats on revs; guides FY25 EPS in-line, revs in-line; announces new $500 mln share repurchase plan

• Reports Q4 (Dec) earnings of $0.20 per share, excluding non-recurring items, in-line with the two analyst estimate of $0.20; revenues rose 7.5% year/year to $1.26 bln vs the $1.23 bln single analyst estimate.
• Co issues in-line guidance for FY25, sees EPS of $0.77-0.85, excluding non-recurring items, vs. $0.81 two analyst estimate; sees FY25 revs of $5.025-5.225 bln vs. $5.04 bln two analyst estimate.
• On Feb. 27, 2025, the Company's Board of Directors announced a share repurchase plan. pursuant to which the Company is authorized to repurchase, through April 30, 2026, up to a maximum aggregate amount of $500 million of shares of Common Stock.

==Block (XYZ) reported earnings on Thur 20 Feb 25 (a/h)

Fintech company Block (SQ) has been trading under a new ticker on the New York Stock Exchange starting Jan. 21: XYZ. 

The company, led by Twitter co-founder Jack Dorsey, has had a history of rebranding itself. In December 2021, the company rebranded and changed its name from Square to Block. 

• Sector: Technology
• Industry: Software - Infrastructure
• HQ: Oakland, California
• https://www.block.xyz

 

EARNINGS MISS: XYZ announced quarterly EPS of $0.71, missing expectations by 18.79%.

The financial services company fell short of net revenue ($6.03 billion vs. the $6.28 billion expected) and adjusted earnings ($0.71 vs. the $0.89 expected). The company, led by chairman and CEO Jack Dorsey, managed to beat on adjusted EBITDA, reporting $757 million (vs. the $741.6 million expected).

==Compass, Inc. (NYSE: COMP) reported earnings on Tue 18 Feb 25 (a/h)

 

NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Compass, Inc. (NYSE: COMP), a leading tech-enabled real estate services company that includes the largest residential real estate brokerage in the United States by sales volume1, announced its financial results for the fourth quarter and full-year ended December 31, 2024.

Q4 2024 Highlights:

• Revenue in Q4 2024 increased by 25.9% year-over-year to $1.4 billion as transactions increased 24.1%. Year-over-year organic revenue growth7 (a non-GAAP measure) was up 20.9%, while revenue growth attributable to the acquisitions completed within the prior 12-months was 5%. 
• GAAP Net loss in Q4 2024 was $40.5 million, an improvement of $43.2 million from a net loss of $83.7 million in Q4 2023. The net loss for Q4 2024 includes non-cash stock-based compensation expense of $31.2 million and depreciation and amortization of $19.7 million.
• Adjusted EBITDA8 (a non-GAAP measure) was $16.7 million in Q4 2024 compared to ($23.7) million in Q4 2023, an improvement of $40.4 million. Excluding M&A related transaction costs of $4.2 million, Adjusted EBITDA in Q4 2024 would have been $20.9 million.
• Operating Cash Flow / Free Cash Flow9 (a non-GAAP measure): During Q4 2024, operating cash flow was $30.5 million and free cash flow was $26.7 million.
• Cash and cash equivalents at the end of Q4 2024 was $223.8 million, and there were no outstanding draws on our revolving credit facility at that time. 

GeneDx (WGS) reported earnings on Tue 18 Feb 25 (b/o)

** charts after earnings ** 

Strong Beat, Guidance: This provider of exome and genome tests is a play on the shift toward personalized medicine and earlier intervention.

During the fourth quarter, GeneDx earned an adjusted 77 cents per share, obliterating forecasts for 16 cents, according to FactSet. Earnings flipped from a year-earlier loss of 49 cents. Sales grew almost 65% to $95.6 million, well ahead of calls for $82.2 million.

GeneDx also guided to $350 million to $360 million in full-year sales. The low end of the outlook easily beat analysts' forecast for $340.4 million.

GeneDx uses AI to provide genomics-related diagnostic testing.

GeneDx provides whole genome and exome sequencing to help identify rare diseases, primarily in children. The genome includes all the DNA in the body, while reading the exome involves looking at only the protein-coding genes.

When performed early, genetic testing can lead to answers that help avoid what Chief Executive Katherine Stueland calls a "diagnostic odyssey." The company only tests for diseases where there is a solution — a clinical study, a dietary change or a treatment.

==Snap (SNAP) reported earnings on Tue 4 Feb 25 (a/h)

 

Snap beats by $0.05, reports revs in-line

• Reports Q4 (Dec) earnings of $0.01 per share, $0.05 better than the FactSet Consensus of ($0.04); revenues rose 14.4% year/year to $1.56 bln vs the $1.55 bln FactSet Consensus.
  • Daily Active Users increased 9% year-over-year to 453 million, above the company's 451 mln forecast.
• Co added, "Active advertisers more than doubled in Q4, with the improvements we have made to our advertising platform driving improved advertiser performance.

==NOV Inc. (NOV) reported earnings on Tue 4 Feb 25 (a/h)

 

NOV Inc. beats by $0.05, beats on revs; guides Q1 revs in-line 

• Reports Q4 (Dec) earnings of $0.41 per share, $0.05 better than the FactSet Consensus of $0.36; revenues fell 1.5% year/year to $2.31 bln vs the $2.24 bln FactSet Consensus.
• Co issues in-line guidance for Q1, sees Q1 revs being down -3% to -1% yr/yr, which we compute as $2.09-2.13 bln vs. $2.12 bln FactSet Consensus.

===Oscar Health, Inc. (OSCR) reported earnings on Tue 4 Feb 25 (a/h)

 

Oscar Health misses by $0.03, misses on revs 

• Reports Q4 (Dec) loss of $0.62 per share, excluding non-recurring items, $0.03 worse than the FactSet Consensus of ($0.59); revenues rose 67.1% year/year to $2.39 bln vs the $2.46 bln FactSet Consensus.
• The Medical Loss Ratio for 2024 increased 10 bps year-over-year to 81.7%, primarily driven by SEP membership growth and an increase in our risk adjustment transfer, partially offset by favorable prior period development. Overall utilization for the year was modestly favorable compared to our pricing expectations. The SG&A Expense Ratio for 2024 improved 520 bps year-over-year to 19.1% for 2024 driven by improved fixed cost leverage and variable cost efficiencies.

===Nucor (NUE) reported earnings on Mon 27 Jan 25 (a/h)

 

 

Nucor beats by $0.58, beats on revs; market conditions are starting to improve

• Reports Q4 (Dec) earnings of $1.22 per share, $0.58 better than the FactSet Consensus of $0.64; revenues fell 8.2% year/year to $7.08 bln vs the $6.76 bln FactSet Consensus.
• Q1 Outlook: Co expects earnings in the steel mills and steel products segments to be similar in 1Q25 as compared to 4Q24. Earnings in the raw materials segment are expected to decrease in 1Q25 relative to 4Q24. Co expects higher corporate, administrative and tax impacts in Q1 than realized in Q4 which may result in lower net earnings overall.
• "While steel demand softened throughout 2024, market conditions are starting to improve and should gain momentum as we work our way into 2025. The U.S. economy is still on the front end of several steel-intensive megatrends and as America's largest and most diversified steel producer, Nucor is well positioned to supply those needs."

-==NextEra Energy (NEE) reported earnings on Fri 24 Jan 25 (b/o)

• The Co. reports EPS in-line; reaffirms FY25 EPS guidance and long term guidance. Additionally, on conference call says it will collaborate with GE Vernova (GEV); says the two companies plan to collaborate to identify key locations on the energy grid that would benefit from new generation. 

NextEra Energy reports fourth-quarter and full-year 2024 financial results 

• NextEra Energy delivers strong full-year 2024 financial and operational results 

• FPL grows regulatory capital employed by approximately 10% year-over-year and continues to keep customer bills as low as possible while delivering reliable electricity 

• NextEra Energy Resources achieves another record year of new renewables and storage origination, adding more than 12 gigawatts to its backlog 

JUNO BEACH, Fla. - NextEra Energy, Inc. (NYSE: NEE) today reported 2024 fourth-quarter net income attributable to NextEra Energy on a GAAP basis of $1.203 billion, or $0.58 per share, compared to $1.210 billion, or $0.59 per share, for the fourth quarter of 2023. On an adjusted basis, NextEra Energy's 2024 fourth-quarter earnings were $1.095 billion, or $0.53 per share, compared to $1.067 billion, or $0.52 per share, in the fourth quarter of 2023. 

For the full year 2024, NextEra Energy reported net income attributable to NextEra Energy on a GAAP basis of $6.946 billion, or $3.37 per share, compared to $7.310 billion, or $3.60 per share, in 2023. On an adjusted basis, NextEra Energy's full-year 2024 earnings were $7.063 billion, or $3.43 per share, compared to $6.441 billion, or $3.17 per share, in 2023, which represents year-over-year growth in adjusted earnings per share of approximately 8.2%.

NextEra Energy, Inc.
NextEra Energy, Inc. (NYSE: NEE) is a leading clean energy company headquartered in Juno Beach, Florida. NextEra Energy owns Florida Power & Light Company, which is America's largest electric utility that sells more power than any other utility, providing clean, affordable, reliable electricity to more than 6 million customer accounts, or more than 12 million people across Florida. NextEra Energy also owns a competitive clean energy business, NextEra Energy Resources, LLC, which, together with its affiliated entities, is the world's largest generator of renewable energy from the wind and sun and a world leader in battery storage. Through its subsidiaries, NextEra Energy generates clean, emissions-free electricity from seven commercial nuclear power units in Florida, New Hampshire and Wisconsin. A Fortune 200 company, NextEra Energy has been recognized often by third parties for its efforts in sustainability, corporate responsibility, ethics and compliance, and diversity. For more information about NextEra Energy companies, visit these websites: www.NextEraEnergy.com, www.FPL.com, www.NextEraEnergyResources.com.

==CSX (CSX) reported earnings on Thur 23 Jan 25 (a/h)

 

CSX reports EPS in-line, revs in-line

• Reports Q4 (Dec) earnings of $0.42 per share, excluding non-recurring items, in-line with the FactSet Consensus of $0.42; revenues fell 3.8% year/year to $3.54 bln vs the $3.56 bln FactSet Consensus.
• CSX's operating margin was 31.3% for the quarter, and adjusted operating margin was 34.3%.

==Ally Financial (ALLY) reported earnings on Wed 22 Jan 25 (b/o)

 

Ally Financial beats by $0.21, beats on revs; to sell its credit card business to CardWorks

• Reports Q4 (Dec) earnings of $0.78 per share, excluding non-recurring items, $0.21 better than the FactSet Consensus of $0.57; adjusted revenues rose 3.6% year/year to $2.09 bln vs the $2.02 bln FactSet Consensus.
• Also, co and CardWorks announce that they have entered into a definitive agreement for CardWorks, and its wholly-owned bank subsidiary, Merrick Bank, to acquire Ally's credit card business, including a portfolio of $2.3 bln in credit card receivables with 1.3 mln active cardholders as of Dec. 31, 2024.
• "Ally's decision to sell its credit card business is part of our broader strategy to pursue a more focused approach, enabling us to simplify and streamline our structure, prioritize our core businesses, and drive improved returns," said Ally CEO Michael Rhodes. The transaction is expected to close in 2025, subject to the completion of customary closing conditions.
• Co says the sale enables Ally to be more focused on its core businesses; acquisition enhances CardWorks' position as a leading credit card issuer and servicer.

===Amphenol (APH) reported earnings on Wed 22 Jan 25 (b/o)

 

Amphenol beats by $0.05, beats on revs; guides Q1 EPS above consensus, revs above consensus

• Reports Q4 (Dec) earnings of $0.55 per share, excluding non-recurring items, $0.05 better than the FactSet Consensus of $0.50; revenues rose 29.8% year/year to $4.32 bln vs the $4.06 bln FactSet Consensus.
• Co issues upside guidance for Q1, sees EPS of $0.49-0.51, excluding non-recurring items, vs. $0.48 FactSet Consensus; sees Q1 revs of $4.00-4.10 bln vs. $3.93 bln FactSet Consensus.

=-=Pure Storage (PSTG) reported earnings on Tue 3 Dec 24 (a/h)

 

 Pure Storage beats by $0.09, beats on revs; guides Q4 revs above consensus 

• Reports Q3 (Oct) earnings of $0.50 per share, excluding non-recurring items, $0.09 better than the FactSet Consensus of $0.41; revenues rose 9.0% year/year to $831.1 mln vs the $814.9 mln FactSet Consensus.
• Subscription annual recurring revenue (ARR) $1.6 billion, up 22% year-over-year.
• Remaining performance obligations (RPO) $2.4 billion, up 16% year-over-year.
• Co issues upside guidance for Q4, sees Q4 revs of $867 mln vs. $855.87 mln FactSet Consensus. Sees Non-GAAP Operating Margin of 15.6%.